Skip to main content
Premium Trial:

Request an Annual Quote

NIH s Zerhouni Tries to Reassure Industry That New Ethics Rules Do Not Impede Collaborations

NEW YORK, March 28 (GenomeWeb News) - Elias Zerhouni, director of the National Institutes of Health, sent an open letter addressed to "industrial partners" last week that sought to reassure them that NIH will continue to work with industry despite recent changes in its conflict-of-interest rules.

 

The March 25 letter, distributed through an e-mail listserve from the NIH's office of technology transfer, states that the new rules do not prevent NIH employees from engaging in official activities or collaborations with industry. "The NIH and its investigators will continue to work with our industrial partners and maintain constructive interactions that remain untainted by bias and conflict," the letter said. "Strategic partnerships between NIH, private industry, and nonprofit organizations will continue to be a key element of translating biomedical research from the bench to the bedside."

 

Such collaborations can be informal exchanges of scientific information and preliminary discussions, as well as more formal Cooperative Research and Development Agreements.

 

The director's message follows new conflict of interest rules for NIH employees that were announced on Feb. 1 and can be viewed here.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.